I know everything I am looking for is here, watch movies, watch series, education, games, exams, news, current events and many more.
Major pharmacy chains CVS and Walgreens announced Friday they would begin selling the abortion pill mifepristone. The pharmacy chains concurrently said Friday they had received Risk Evaluation and Mitigation Strategy (REMS) certifications from the Food and Drug Administration (FDA), which prescribers and pharmacies are required to have to dispense mifepristone. The REMS program is required…
Republican presidential candidate Vivek Ramaswamy said that he believes the Supreme Court should overturn the Food and Drug Administration’s (FDA) approval of the abortion pill mifepristone. Ramaswamy said at a CNN town hall in Iowa on Wednesday that the case, which the court agreed earlier on Wednesday to hear, is about the authority that regulatory…
A United States District Judge on Thursday dismissed portions of a lawsuit brought against West Virginia by a manufacturer of a generic version of the abortion drug mifepristone over the state’s restrictions on the medication. GenBioPro sued the state’s attorney general in January, claiming the abortion ban and other restrictions have caused it “significant, ongoing economic…
Editor’s note: The Hill’s Morning Report is our daily newsletter that dives deep into Washington’s agenda. To subscribe, click here or fill out the box below. Close Thank you for signing up! Subscribe to more newsletters here The latest in politics and policy. Direct to your inbox. Sign up for the Morning Report newsletter There…
The Texas ruling against the Food and Drug Administration’s (FDA) approval of mifepristone, a pill that can be used for an abortion up to 10 weeks of pregnancy, could have major implications for abortion access throughout the country. U.S. District Judge Matthew Kacsmaryk issued his ruling, which could stop the prescribing and distribution of mifepristone,…
The Hill’s Morning Report — Swiss bank troubles prompt question: More ahead? Editor’s note: The Hill’s Morning Report is our daily newsletter that dives deep into Washington’s agenda. To subscribe, click here or fill out the box below. Close Thank you for signing up! Subscribe to more newsletters here The latest in politics and policy….